O-2484

O-2484
[[File:|frameless|220px|alt=|]]
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status	Research chemical
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

O-2484 is a synthetic cannabinoid that has been studied for its potential effects on the endocannabinoid system. It is a member of the class of compounds known as cannabinoid receptor agonists, which interact with the CB1 and CB2 receptors in the body.

Chemical Structure and Properties

O-2484 is characterized by its unique chemical structure, which includes a core structure typical of many synthetic cannabinoids. The exact molecular formula and structure are proprietary or not widely published, but it is known to be a potent agonist at cannabinoid receptors.

Pharmacology

O-2484 acts primarily as an agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. This system plays a crucial role in regulating various physiological processes, including pain sensation, mood, appetite, and memory. The activation of these receptors by O-2484 can lead to effects similar to those produced by tetrahydrocannabinol (THC), the primary psychoactive component of Cannabis.

Mechanism of Action

The mechanism of action of O-2484 involves binding to the CB1 and CB2 receptors, which are G-protein coupled receptors. Upon binding, O-2484 activates these receptors, leading to a cascade of intracellular events that modulate neurotransmitter release and influence various signaling pathways.

Research and Potential Applications

Research on O-2484 is primarily focused on its potential therapeutic applications. Studies have explored its effects on pain management, inflammation, and neuroprotection. However, as with many synthetic cannabinoids, the safety profile and potential for adverse effects are areas of active investigation.

Safety and Legal Status

As a research chemical, O-2484 is not approved for medical use and is typically used in laboratory settings. Its legal status varies by country, and it may be subject to restrictions or bans due to its potential for abuse and lack of clinical testing.

Also see

• Cannabinoid receptor
• Endocannabinoid system
• Synthetic cannabinoids
• CB1 receptor
• CB2 receptor